Wolf, and M.C Petrie, for the STEP-HFpEF Trial Committees and Investigators* Relevant literature The STEP-HFpEF group has previously published the study design and baseline patient characteristics of this RCT 2 Relevant RCTs below: Relevant Guidelines 2022 AHA/ACC/HFSA Guidelines of the Management of Heart Failure: A Report of the ACC/AHA Joint Committee on Clinical Practice Guidelines
Common side effects include gastrointestinal issues, which often resolve on their own within a few days
Its physiology is real and its safety profile is reasonable, but the responsible provider frames it as antioxidant and detoxification support , not as a proven treatment for specific diseases or a guaranteed cosmetic result
Wellness is not a destination but a series of small, informed choices made every day
Ozempic contains semaglutide as its active ingredient, which slows down the gastric emptying, leading to nausea and a feeling of fullness
not yet approved Tirzepatide : FDA-approved as Mounjaro (2022) for T2D and Zepbound (2023) for obesity Advantage : Tirzepatide Side Effect Profile# Retatrutide : GI side effects common